SPTX

NASDAQ Healthcare

Seaport Therapeutics, Inc. - Common Stock

Biotechnology

Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects. All therapeutic candidates in development are based on this platform, with research and development activities focused on neuropsychiatric medicines. The company serves clinicians and key opinion leaders in the healthcare and neuropsychiatric medicine sectors. The company was founded in 2024 and is based in Boston, Massachusetts.

�� 市场数据
价格$19.84
成交量4,692,704
市值1.01B
52周最高$23.00
52周最低$19.50
在Yahoo Finance查看 →
🎯 投资策略评分

SPTX 在各投资策略中的评分。分数越高，越符合该策略目标。

💰 Dividend Daddy 30/100
高股息率 + 低波动性
🚀 Moon Shot 13/100
高增长潜力（高贝塔 + 超卖）
🔪 Falling Knife 62/100
逆向投资（超卖 + 低于移动均线）
🎈 Over-Hyped 34/100
超买股票（潜在做空标的）
🐋 Institutional Whale 25/100
大盘、机构级别股票
🔍 策略解读

最佳匹配： 🔪 Falling Knife (62/100) — 此策略 逆向投资（超卖 + 低于移动均线）.

评分最低的策略： 🚀 Moon Shot (13/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →

📚 了解更多
本页指标
教育文章
网站资源
在文本中查找 SPTX in your text

粘贴任何文章、记录或帖子 — 工具将提取 SPTX 以及每一个其他隐藏的股票代码。

试试股票代码提取器 →

免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-05-01.